Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
41 HKD | -2.03% | +13.28% | -4.21% |
Apr. 30 | Innovent Biologics, Inc. Reports Revenue Results for the First Quarter of 2024 | CI |
Apr. 30 | Innovent Biologics, Inc. Appoints Samuel Zhang as Global Chief Business Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.21% | 8.69B | |
-3.79% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.94% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+5.17% | 8.73B |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.
- Innovent Biologics New Cancer Drug Gets NDA from Chinese Authority